Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia

  • Y. K
  • T. K
  • Y. A
  • et al.
ISSN: 1876-4738
N/ACitations
Citations of this article
1Readers
Mendeley users who have this article in their library.

Abstract

Background: The most critical adverse effects of class III drugs are marked QT prolongation and torsade de pointes. Even though intravenous amiodarone (iv-Amio) is a representative class III drug, it peculiarly inhibits both clinical ventricular tachycardia/fibrillation (VT/VF) and proarrhythmic effects.To test the hypothesis that iv-Amio homogeneously prolongs repolarization, we evaluated electrocardiographic changes before and during short-term amiodarone therapy, focusing closely on the ventricular dispersion of repolarization. Methods: Twenty-seven consecutive patients treated with iv-Amio for VT/VF as a first-line antiarrhythmic therapy were enrolled in this study. Twelve-lead electrocardiography was recorded before and during amiodarone therapy to evaluate the following electrocardiographic intervals: R-R, QRS, QT, QRS to T-peak (QTp), and T-peak to T-end (Tp-e; as an index of dispersion of repolarization). Repolarization indices were corrected to the heart rate by Bazett's method (QTc, c-QTp, c-Tp-e). Results: Amiodarone suppressed VT/VF in 19/27 (70%) patients without conferring any proarrhythmic effect. The QTc, c-QTp, and R-R interval were significantly prolonged during amiodarone (476. (plus or minus). 45. ms vs 511. (plus or minus). 45. ms, p<. 0.05; 338. (plus or minus). 40. ms vs 364. (plus or minus). 35. ms, p<. 0.05; 762. (plus or minus). 272. ms vs 870. (plus or minus). 189. ms, p<. 0.05; respectively), whereas the c-Tp-e and QRS durations did not change significantly (139. (plus or minus). 33. ms vs 145. (plus or minus). 41. ms, p=. 0.25; 96. (plus or minus). 20. ms vs 97. (plus or minus). 21. ms, p=. 0.33; respectively). Conclusions: Iv-Amio homogeneously prolongs repolarization and properly inhibits original VT/VF recurrence without inducing torsade de pointes.

Cite

CITATION STYLE

APA

Y., K., T., K., Y., A., R., Y., K., M., K., K., … S., M. (2015). Intravenous amiodarone homogeneously prolongs ventricular repolarization in patients with life-threatening ventricular tachyarrhythmia. Journal of Cardiology, 66(2), 161–167. Retrieved from http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L604973280

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free